Response Magazine Site Response Expo Site Direct Response Market Alliance Site Job Board


   Log in
The Voice

FTC Loses Contempt Action Against Garden of Life

6 Mar, 2012 By: Linda A. Goldstein

The Federal Trade Commission (FTC) suffered a striking loss in its efforts to hold Garden of Life, the marketer of various dietary supplements, in contempt of a previous consent order entered into by the company with the FTC in 2006.

The FTC alleged that Garden of Life violated the order by: falsely claiming that its Raw Vitamin C, Raw Calcium and Grow Bone System contained no soy allergens; making baseless claims that its Ocean Kids Omega 3 product has brain boosting powers and other benefits for children; and making unfounded claims that RAW Calcium and Grow Bone System are superior to other calcium supplements. The court ruled that the FTC had failed to prove that any of the challenged claims violated the previous consent order. There are a number of fascinating highlights from the case that should be of interest to every DR marketer.

First, the court expressly stated at the outset of the decision that in order for a defendant to be held in contempt of an order, the order must be clear, definite and unambiguous. While the court did not in this case ultimately need to address the issue of whether the original Garden of Life consent order was sufficiently clear and unambiguous, its warning on this issue is likely to fuel the FTC’s current efforts to move away from the more general “competent and reliable scientific evidence” substantiation standard to a more specific requirement that certain claims be supported by one or more clinical studies.

Secondly, the Court’s analysis of the “no soy allergen” claim should be music to the ears of marketers who routinely rely upon their suppliers for their ingredient claims. Garden of Life defended this claim by arguing that it was not the manufacturer of the product, and that it had been assured by the manufacturer that the product did not contain any allergens. The court agreed with Garden of Life and expressly ruled that the allergen statements, prepared by the manufacturer, constitute “competent and reliable scientific evidence.”

The court’s approach to the Ocean Kids Omega 3 product claims is particularly noteworthy. The FTC will often retain its own experts to critique a defendant’s studies or to contradict the expert opinions upon which a defendant has relied, and the courts have historically given great deference to the FTC’s experts. In this case, the Court ruled that simply because the FTC’s expert disagreed with Garden of Life’s expert on certain aspects of a study’s trial design does not mean that Garden of Life’s expert opinion did not constitute competent and reliable scientific evidence.

Perhaps the most interesting aspect of the case involved the FTC’s challenge to alleged claims by Garden of Life that its Raw Calcium and Grow Bone System offered superior health benefits to other calcium supplements. The court took a very narrow view of the existing consent order. The order provision at issue prohibited Garden of Life from making representations about the “absolute or comparative health benefits of its products.” The court determined that this provision only applied to claims about the health benefits of Garden of Life products or to claims that individuals who use Garden of Life products would achieve certain benefits compared to those who do not use the product. In the court’s view, the FTC’s interpretation of the order provision in question was not a sufficiently tailored interpretation of the injunctive provisions of the consent decree. The court further determined that even if the FTC’s interpretation of the order provision was correct, it had taken Garden of Life’s claims out of context, and the advertising was not making the claims that the FTC had alleged.

This decision will likely have an impact on FTC order provisions in the future, but for those facing initial enforcement actions or contempt proceedings, the court’s analysis and decision certainly provides some useful precedent.

Linda Goldstein is chair of the Advertising, Marketing and Media division of Manatt, Phelps & Phillips LLP, based in the firm’s New York office. She can be reached at (212) 790-4544 or [email protected].

Add Comment

DRMA Putting Unity in Community

The DRMA is vibrant and growing marketing alliance with one singular focus: to serve and support marketing professionals that utilize performance-based, trackable and measurable marketing.

If you are responsible for a product or service that is sold and marketed to a consumer via direct response, digital or data-driven tactics, or if you are part of the supply chain that helps facilitate a marketing and sales campaign, then the DRMA is a vital organization to join.

The DRMA uses a combination of education and networking to foster clear channels of communication and transparent pathways to nurture long term relationships in a comfortable and neutral environment.

DRMA Voice
FTC Suffers Another Setback in RCT Crusade     3 Nov, 2015

Article By: William I. Rothbard

The Federal Trade Commission’s (FTC) crusade to mandate randomized controlled trials (RCT) for...More>>

What the FTC’s Win in Wyndham May Mean for Marketers     3 Nov, 2015

Article By: Linda A. Goldstein, Holly Melton

On the heels of the Wyndham decision recently issued by the United States Court of Appeals for the...More>>

It Was an Interesting Month for Telemarketers     3 Nov, 2015

Article By: Jeffrey D. Knowles, Daniel S. Blynn

The proverb “May you live in interesting times” was especially apropos for telemarketers during...More>>

The Risks and Rules of Auto-Renewal     13 Oct, 2015

Article By: Jeffrey Richter

Many direct marketers adopt automatic renewal policies in connection with sales or lease programs...More>>

FTC Says You Can’t ‘Gag’ Truthful Negative Consumer Reviews     13 Oct, 2015

Article By: Gregory J. Sater

In September, the Federal Trade Commission (FTC) filed suit against a marketer doing business as...More>>

Breaking News
Fantasy Sports Challenges Could Hurt Networks     25 Nov, 2015

News By: Doug McPherson

NEW YORK – Some analysts believe the legal challenges facing fantasy sports companies operations...More>>

Comcast’s New Streaming Service Riles Neutrality Advocates     25 Nov, 2015

News By: Doug McPherson

PHILADELPHIA – Comcast’s new service, called “Stream,” lets Comcast’s broadband-only...More>>

OTT Services to Reach 306 Million by 2020     25 Nov, 2015

News By: Doug McPherson

DALLAS – Over-the-top (OTT) video platforms will reach 306 million people in 200 countries by...More>>

Vizio and Vendors Face Lawsuit Over Tracking Viewers     25 Nov, 2015

News By: Doug McPherson

IRVINE, Calif. – Less than a week after reports surfaced that Vizio tracks TV viewers and shares...More>>

AT&T Looks to End Throttling Case in Appeals Court     25 Nov, 2015

News By: Doug McPherson

DALLAS – AT&T has filed an appellate brief saying the Federal Trade Commission (FTC) lacks...More>>

DRMA Spotlight
DRMA Spotlight: 30 Years in, Cannella Response Television Keeps Looking Ahead     1 Oct, 2015

Article By: Thomas Haire

It’s been one year since we turned the DRMA Spotlight on Burlington, Wis., and Los Angeles-based...More>>